These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Successful management of serious disopyramide poisoning. Holt DW; Helliwell M; O'Keeffe B; Hayler AM; Marshall CB; Cook G Postgrad Med J; 1980 Apr; 56(654):256-60. PubMed ID: 7433327 [TBL] [Abstract][Full Text] [Related]
7. [Acute voluntary or accidental disopyramide poisoning. A multicentric study of 106 cases (author's transl)]. Jaeger A; Sauder P; Tempe JD; Mantz JM Nouv Presse Med; 1981 Oct; 10(35):2883-7. PubMed ID: 7290940 [TBL] [Abstract][Full Text] [Related]
8. Disopyramide (Norpace) distribution at autopsy of an overdose case. Anderson WH; Stafford DT; Bell JS J Forensic Sci; 1980 Jan; 25(1):33-9. PubMed ID: 7391781 [TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic effects of disopyramide and procainamide in open-chest animals]. Binetti G; Branzi A; Malini PL; Specchia S; Magelli C; Zannoli R; Magnani B G Ital Cardiol; 1978; 8(12):1314-9. PubMed ID: 738572 [TBL] [Abstract][Full Text] [Related]
11. A study of the acute electrophysiological and cardiovascular action of disopyramide in man. Marrott PK; Ruttley MS; Winterbottam JT; Muir JR Eur J Cardiol; 1976 Sep; 4(3):303-12. PubMed ID: 964279 [TBL] [Abstract][Full Text] [Related]
12. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)]. Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746 [TBL] [Abstract][Full Text] [Related]
13. Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs. Walsh RA; Horwitz LD Circulation; 1979 Nov; 60(5):1053-8. PubMed ID: 487539 [TBL] [Abstract][Full Text] [Related]
14. Acute effects of conventional oral dose of disopyramide on left atrial and ventricular functions. Arakawa M; Miwa H; Noda T; Kagawa K; Nishigaki K; Ito Y; Kawada T; Hirakawa S Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):253-9. PubMed ID: 8314654 [TBL] [Abstract][Full Text] [Related]
15. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units]. Boland J; Lisin N; Marcelle R; Carlier J Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909 [TBL] [Abstract][Full Text] [Related]
16. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555 [TBL] [Abstract][Full Text] [Related]
18. Acute intoxication with diisopyramide: clinical and experimental study by hemoperfusion an Amberlite XAD 4 resin. Gosselin B; Mathieu D; Chopin C; Wattel F; Dupuis B; Haguenoer JM; Desprez M Clin Toxicol; 1980 Oct; 17(3):439-49. PubMed ID: 7449357 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of combined administration of verapamil and disopyramide in dogs. Lee JT; Davy JM; Kates RE J Cardiovasc Pharmacol; 1985; 7(3):501-7. PubMed ID: 2410681 [TBL] [Abstract][Full Text] [Related]
20. Disopyramide plasma and myocardial tissue concentrations as they relate to antiarrhythmic activity. Patterson E; Stetson P; Lucchesi BR J Cardiovasc Pharmacol; 1979; 1(5):541-50. PubMed ID: 94410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]